Latest News of Indian Stock Markets | Nifty | Sensex | IPO | F&O | Delta Trading | Personal Finance | Tax
Biocon Share Price surged by 4.5% after receiving approval from the US Food and Drug Administration (FDA) for its Malaysian insulin facility, overcoming a significant regulatory hurdle and paving the way for future product launches. This clearance marks an important milestone for Biocon, eliminating past barriers and setting the company up for future expansion. The…
Biocon share price surged over 7% on January 7, 2025, marking a significant rally. By 10:45 am, Biocon shares were trading at Rs 384.50 on the Bombay Stock Exchange (BSE), reflecting a 7.22% increase. This surge came after the company received a rating upgrade from international brokerage Jefferies, which raised its target price for the…